Information related to FDA’s preparation for the fourth reauthorization of GDUFA will be hosted on this page as it becomes available.
Similar Posts
AlzClipp / UniUni – 711274 – 07/29/2025
Unapproved New Drugs/MisbrandedBRS Analytical Services, LLC – 711133 – 09/17/2025
CGMP/Finished Pharmaceuticals/AdulteratedWeight Loss Product Notifications
Learn about the warnings for weight loss products that contain hidden drugs and other hidden ingredients.Anesthesia Delivery Systems Recall: GE HealthCare Issues Correction for Certain Carestations due to Risk of Ineffective Ventilation When Used in Volume Control Ventilation (VCV) Mode
GE HealthCare is correcting Carestations that may not ventilate properly in VCV mode. The issue is clearly indicated by alarms; other modes remain effective.Petscript Inc. Paris, TX. 483 issued 09/18/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 09/18/2025
Short Title (70 char) Petscript Inc. Paris, TX. 483 issued 09/18/2025
FEI Number 3010282564
Firm Name Petscript Inc
Record Type 483
State TX
Establishment Type Producer of Sterile and Non-sterileMalaria: Developing Drugs for Treatment
Malaria: Developing Drugs for Treatment